Christine Brostjan
Has grant
Associate Professor for Vascular Biology
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Christine Brostjan is an Associate Professor for Vascular Biology at the Medical University of Vienna, Austria. Her research focuses on abdominal aortic aneurysms, exploring biomarkers, risk factors, and the underlying mechanisms of disease progression. Recent articles authored by Dr. Brostjan highlight topics including the role of tenascin C, the impact of lipoproteins on neutrophil activity, and potential viral associations with aneurysm formation.
Recent Grants
Grant: Close
Changes of monocyte subsets in response to therapy of colorectal cancer
Open Date: 2019-10-01
Close Date: 2023-09-01
Grant: Close
Cellular mediators linking inflammation and thrombosis
Open Date: 2014-03-01
Close Date: 2022-02-01
Grant: Close
Ras Protein Transfer during Trans-Endothelial Migration
Open Date: 2011-09-01
Close Date: 2015-02-28
Grant: Close
Endothelial Activation by Interferon Blocking Antibodies
Open Date: 2007-09-01
Close Date: 2011-08-31
Grant: Close
Retroviral targeting of tumor endothelium
Open Date: 2000-06-01
Close Date: 2002-05-31
Articles (10)
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (10)
Stefan Stojkovic
Medical University of Vienna
Edyta Paradowska
Professor
Institute of Medical Biology Polish Academy of Sciences
Herbert Stangl
Head of Department / a.o. Univ. Prof. Dr.
Medical University of Vienna
Bruno K Podesser
Medical University of Vienna
Wolf Eilenberg
Medical University of Vienna
Christoph Neumayer
Medical University of Vienna
Martin A. Funovics
Medical University of Vienna
Rudolf Oehler
Associate Professor
Medical University of Vienna
Nahla Ibrahim
Medical University of Vienna
Johannes Klopf
Medical University of Vienna
Make your next move.
Prepare your application
Review drafts before you send them.